Deutsch English Français

Contact

EP3233113

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP3233113

EP3233113 - EBOLAVIRUS AND MARBURGVIRUS VACCINES [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 18.11.2022 Database last updated on 14.06.2024
Former	Grant of patent is intended Status updated on 01.03.2022
Former	Examination is in progress Status updated on 22.06.2018
Former	Request for examination was made Status updated on 22.09.2017
Former	The international publication has been made Status updated on 15.06.2017
Most recent event Tooltip	18.11.2022	Application deemed to be withdrawn	published on 21.12.2022 [2022/51]
Applicant(s)	For all designated states CureVac AG Friedrich-Miescher-Straße 15 72076 Tübingen / DE
	[2021/10]
Former [2017/43]	For all designated states CureVac AG Paul-Ehrlich-Str. 15 72076 Tübingen / DE
Inventor(s)	01 / RAUCH, Susanne c/o IP Department CureVac AG Friedrich-Miescher-Str. 15 72706 Tübingen / DE
	02 / JASNY, Edith c/o IP Department CureVac AG Friedrich-Miescher-Str. 15 72706 Tübingen / DE
	[2020/41]
Former [2018/16]	01 / RAUCH, Susanne Im Winkelrain 18 72076 Tübingen / DE
	02 / JASNY, Edith Möhringer Str. 159 70199 Stuttgart / DE
Former [2017/43]	01 / RAUCH, Susanne Mörikestrasse 11 72076 Tübingen / DE
	02 / JASNY, Edith Dorfstrasse 70 72074 Tübingen / DE
Representative(s)	Graf von Stosch, Andreas, et al Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstraße 22 80538 München / DE
	[2017/43]
Application number, filing date	15813814.9	16.12.2015
	[2017/43]
	WO2015EP80108
Priority number, date	WO2014EP03371	16.12.2014 Original published format: PCT/EP2014/003371
	[2017/43]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2016097065
	Date:	23.06.2016
	Language:	EN
	[2016/25]
	Type:	A1 Application with search report
	No.:	EP3233113
	Date:	25.10.2017
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 23.06.2016 takes the place of the publication of the European patent application.
	[2017/43]
Search report(s)	International search report - published on:	EP	23.06.2016
Classification	IPC:	A61K39/00, A61K39/12, C12N15/67	[2017/43]
	CPC:	A61K39/12 (EP,US); C07K14/005 (US); C12N7/00 (US); A61K2039/53 (EP,US); A61K2039/54 (US); A61K2039/575 (EP,US); (+) A61K2039/70 (EP,US); C12N2760/14134 (EP,US); C12N2760/14234 (EP,US); C12N2830/50 (EP,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/43]
Title	German:	EBOLAVIRUS- UND MARBURGVIRUS-IMPFSTOFFE	[2017/43]
	English:	EBOLAVIRUS AND MARBURGVIRUS VACCINES	[2017/43]
	French:	VACCINS CONTRE LE VIRUS EBOLA ET LE VIRUS MARBURG	[2017/43]
Entry into regional phase	02.06.2017	National basic fee paid
	02.06.2017	Designation fee(s) paid
	02.06.2017	Examination fee paid
Examination procedure	02.06.2017	Examination requested [2017/43]
	02.06.2017	Date on which the examining division has become responsible
	02.02.2018	Amendment by applicant (claims and/or description)
	25.06.2018	Despatch of a communication from the examining division (Time limit: M04)
	05.11.2018	Reply to a communication from the examining division
	07.02.2019	Despatch of a communication from the examining division (Time limit: M06)
	14.08.2019	Reply to a communication from the examining division
	08.11.2019	Despatch of a communication from the examining division (Time limit: M04)
	17.03.2020	Reply to a communication from the examining division
	23.07.2020	Despatch of a communication from the examining division (Time limit: M04)
	01.12.2020	Reply to a communication from the examining division
	29.03.2021	Despatch of a communication from the examining division (Time limit: M06)
	08.10.2021	Reply to a communication from the examining division
	02.03.2022	Communication of intention to grant the patent
	13.07.2022	Application deemed to be withdrawn, date of legal effect [2022/51]
	02.08.2022	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2022/51]
Fees paid	Renewal fee
	30.10.2017	Renewal fee patent year 03
	15.10.2018	Renewal fee patent year 04
	23.12.2019	Renewal fee patent year 05
	29.10.2020	Renewal fee patent year 06
	17.12.2021	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XY]WO2006037038 (US GOV HEALTH & HUMAN SERV [US], et al) [X] 1-4,6,22,23,26-28,32 * page 9, line 27 - line 32; claims 1-6, 11-13, 16 * * page 28; figure 8 * [Y] 19;
		[X]US2010034843 (HART MARY KATE [US], et al) [X] 1-4,23,26-28,32 * paragraph [0068] - paragraph [0070]; sequence 1 *;
		[XYI]WO2013120499 (CUREVAC GMBH [DE], et al) [X] 1,2,5,7-12,14,20-27 * page 8 - page 12; claims 1-3,6-9,12,13-16 * * page 28, line 12 - line 14 * * page 35, line 3 - line 5 * * page 59 - page 70 * [Y] 13,15-19,31,34 [I] 28-30,32,33;
		[YD]WO2013143700 (CUREVAC GMBH [DE], et al) [YD] 13,15-19 * claims 1-89 *;
		[Y]WO2014158123 (US ARMY MEDICAL RES INST OF INFECTIOUS DISEASE A RES LAB OWNED AND OPERATED BY THE U S GOVERNMENT AS [US], et al) [Y] 31,34 * claims 1-14 *;
		[A] - KRISHNAMURTHY KONDURU ET AL, "Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice", VACCINE, ELSEVIER LTD, GB, (20110405), vol. 29, no. 16, doi:10.1016/J.VACCINE.2011.01.113, ISSN 0264-410X, pages 2968 - 2977, XP002685794 [A] 4 * page 2969 * DOI: http://dx.doi.org/10.1016/J.VACCINE.2011.01.113
		[A] - JASON S. RICHARDSON ET AL, "Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine", PLOS ONE, (20090423), vol. 4, no. 4, doi:10.1371/journal.pone.0005308, page e5308, XP055194524 [A] 4 * page 6 * DOI: http://dx.doi.org/10.1371/journal.pone.0005308

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p